Chemoinformaics analysis of Phenol, 4-(3-hydroxy-1-propenyl)-
| Molecular Weight | 150.177 | nRot | 2 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 20 |
| Exact Molecular Weight | 150.068 | nRing | 1 |
| Solubility: LogS | -2.479 | nHRing | 0 |
| Solubility: LogP | -0.005 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 23.3019 |
| nHD | 2 | BPOL | 10.0321 |
| QED | 0.239 |
| Synth | 3.853 |
| Natural Product Likeliness | 1.786 |
| NR-PPAR-gamma | 0.679 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.481 |
| HIA | 0.717 |
| CACO-2 | -6.294 |
| MDCK | 0.0000057 |
| BBB | 0.36 |
| PPB | 0.954142 |
| VDSS | 0.834 |
| FU | 0.0538697 |
| CYP1A2-inh | 0.152 |
| CYP1A2-sub | 0.031 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.655 |
| CYP2d6-inh | 0.081 |
| CYP2d6-sub | 0.276 |
| CYP3a4-inh | 0.209 |
| CYP3a4-sub | 0.042 |
| CL | 8.718 |
| T12 | 0.727 |
| hERG | 0.053 |
| Ames | 0.793 |
| ROA | 0.381 |
| SkinSen | 0.787 |
| Carcinogencity | 0.565 |
| EI | 0.031 |
| Respiratory | 0.07 |
| NR-Aromatase | 0.841 |
| Antiviral | No |
| Prediction | 0.897849 |